Is novelty overrated?
Source abstract
Abstract
Nanomaterial risks are often considered in terms of novel material behaviours. But, as Andrew D. Maynard explains, does this framing end up obscuring some risks, while overplaying others?
The source flagged this abstract for review. Check formulas and completeness against the original publication.
Source: openaire · Quality: needs review · Source record ↗
Source flags: short_text
Source flags: short_text
Research context
OpenAlex topics: Nanoparticles: synthesis and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (5)
Show source-provided references
1. Hansen, S. F., Maynard, A., Baun, A., Tickner, J. A. & Bowman, D. M. in Late Lessons from Early Warnings: Science, Precaution, Innovation 562–591 (European Environment Agency, 2013).
2. Maynard, A. D., Warheit, D. & Philbert, M. A. Toxicol. Sci. 120, S109–S129 (2011).10.1093/toxsci/kfq372 ↗
3. Maynard, A. D. in Nanotechnology Environmental Health and Safety: Risks, Regulation, and Management (Micro and Nano Technologies) 2nd edn (eds Hull, M. & Bowman, B. M.) 339–365 (William Andrew, 2014).
4. Donaldson, K. & Poland, C. A. Curr. Opin. Biotechnol. 24, 724–734 (2013).10.1016/j.copbio.2013.05.003 ↗
5. Nohynek, G. J., Lademann, L., Ribaud, C. & Roberts, M. S. Crit. Rev. Toxicol. 37, 251–277 (2007).10.1080/10408440601177780 ↗